Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06119867

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Comparison Between the European and Japanese Pathological Investigation for Colon Cancer (SPACE)

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
430 (estimated)
Sponsor
Russian Society of Colorectal Surgeons · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.

Conditions

Interventions

TypeNameDescription
PROCEDUREJapanese pathological investigationJapanese pathological investigation
PROCEDUREEuropean pathological investigationThe European pathology evaluation method involves the analysis of fresh and intact specimens. Pathologists carefully inspect the entire specimen's appearance and assess the surgical resection plane and capture complete photographs for documentation purposes before further sectioning the specimen. During specimen processing, the CRM is initially marked with ink or other markers. After fixation, macroscopic data are recorded, and the entire length of the intestine is cut into cross-sections at intervals of 3-4 millimeters. These sections are then undergoing subsequent systematic pathological examination. However, the surgeon will be involved in the Japanese pathological investigation method. Intraoperative markings will be made 10 cm bilaterally from the primary tumor area. The resected colon will be incised at 1 cm intervals, after which the pericolic lymph nodes will be harvested. Each single retrieved lymph node will be packed up independently and will be examined by the pathologist.

Timeline

Start date
2023-11-14
Primary completion
2025-10-12
Completion
2025-12-01
First posted
2023-11-07
Last updated
2024-04-09

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT06119867. Inclusion in this directory is not an endorsement.